Published in Infect Immun on September 01, 1979
Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med (1984) 3.79
The rate of oxygen utilization by cells. Free Radic Biol Med (2011) 1.36
Escherichia coli lipopolysaccharides diminish and enhance cell function of human polymorphonuclear leukocytes. Infect Immun (1983) 1.35
Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide. Infect Immun (1983) 1.32
Effect of staphylococcal alpha-toxin on phagocytosis of staphylococci by human polymorphonuclear leukocytes. Infect Immun (1982) 1.17
Endotoxin-induced selective dysfunction of rabbit polymorphonuclear leukocytes in response to endogenous chemotactic factors. Infect Immun (1985) 1.09
Role of fibronectin in human monocyte and macrophage bactericidal activity. Infect Immun (1985) 1.05
Stimulation of human polymorphonuclear leukocyte oxidative metabolism by type 1 pili from Escherichia coli. Infect Immun (1987) 1.04
Bacterial-lipopolysaccharide-induced release of lactoferrin from human polymorphonuclear leukocytes: role of monocyte-derived tumor necrosis factor alpha. Infect Immun (1987) 1.02
Induction of human granulocyte chemiluminescence by bacterial lipopolysaccharides. Infect Immun (1987) 0.97
Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest (1981) 0.97
Serum-mediated depression of neutrophil chemiluminescence following blunt trauma. Ann Surg (1985) 0.88
Contributions of C1q, bacterial lipopolysaccharide, and porins during attachment and ingestion phases of phagocytosis by murine macrophages. Infect Immun (1986) 0.86
Burn wound sepsis may be promoted by a failure of local antibacterial host defenses. Ann Surg (1987) 0.83
Simple procedure for measuring neutrophil chemiluminescence. J Clin Microbiol (1981) 0.82
Stimulus-specific effects of endotoxin on superoxide production by rabbit polymorphonuclear leukocytes. Yale J Biol Med (1988) 0.77
Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem (1969) 43.83
The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem (1959) 17.39
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26
Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun (1972) 7.50
Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med (1968) 6.91
Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest (1975) 6.25
Functional and metabolic properties of polymorphonuclear leucocytes. II. The influence of a lipopolysaccharide endotoxin. J Exp Med (1960) 5.40
Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med (1978) 4.31
Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem (1971) 4.15
Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes. J Clin Invest (1976) 3.90
Metabolic and morphological observations on the effect of surface-active agents of leukocytes. J Cell Biol (1967) 3.53
Glutathione and the hexose monophosphate shunt in phagocytizing and hydrogen peroxide-treated rat leukocytes. J Biol Chem (1969) 3.29
The origin of the chemiluminescence of phagocytosing granulocytes. J Clin Invest (1976) 2.92
Relationship of glycolytic and oxidative metabolism to particle entry and destruction in phagocytosing cells. Nature (1966) 2.90
Evidence that the superoxide-generating system of human leukocytes is associated with the cell surface. J Clin Invest (1977) 2.77
The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood (1976) 2.76
Inhibition of phagocytosis-associated chemiluminescence by superoxide dismutase. Infect Immun (1974) 2.26
Spontaneous in vitro reduction of nitroblue tetrazolium by neutrophils of adult patients with bacterial infection. N Engl J Med (1971) 2.16
Xanthine oxidase. IV. Participation of iron in internal electron transport. J Biol Chem (1958) 1.89
Effects of anaerobiosis and inhibitors on O2-production by human granulocytes. Blood (1975) 1.85
N.B.T. test stimulated. Lancet (1970) 1.73
Occurrence and control of the phosphogluconate oxidation pathway in normal and leukemic leukocytes. J Biol Chem (1958) 1.72
Initiation of the respiratory burst in human polymorphonuclear neutrophils: a critical review. J Reticuloendothel Soc (1978) 1.52
Symposium on bacterial endotoxins. III. Metabolic effects of endotoxins on mammalian cells. Bacteriol Rev (1961) 1.46
Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes. Infect Immun (1975) 1.46
The metabolism of human polymorphonuclear leukocytes. Ann N Y Acad Sci (1955) 1.44
The mechanism of the entry of dye into neutrophils in the nitroblue tetrazolium (NBT) test. Clin Sci Mol Med (1973) 1.38
The requirement for membrane sialic acid in the stimulation of superoxide production during phagocytosis by human polymorphonuclear leukocytes. J Exp Med (1976) 1.35
Endotoxin-binding substances from human leukocytes and platelets. Infect Immun (1975) 1.30
Comparison of NADH and NADPH oxidase activities in granules isolated from human polymorphonuclear leukocytes with a fluorometric assay. J Clin Invest (1977) 1.22
Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis. J Clin Invest (1978) 1.15
Chemiluminescence spectra of human myeloperoxidase and polymorphonuclear leukocytes. Infect Immun (1977) 1.14
Mechanism of endotoxin interaction with human leucocytes. Br J Haematol (1968) 1.09
Effects of bacterial endotoxin on the fibrinolytic activity of normal human leukocytes. Blood (1971) 0.92
Surface sulphydryl groups and hexose monophosphate pathway activity in resting human polymorphonuclear leucocytes. Br J Haematol (1976) 0.91
Familial deficiency of glutathione reductase in human blood cells. Blood (1976) 0.90
Cell damage and dye reduction in the quantitative nitroblue tetrazolium (NBT) test. Clin Exp Immunol (1975) 0.88
Studies with radioactive endotoxin. III. Localization of 3H-labelled endotoxin in the formed elements of the blood and detection of endotoxin in calf blood with the Limulus amebocyte lysate. Can J Comp Med (1974) 0.87
Serum and cellular factor involvement in nitroblue tetrazolium (NBT) reduction by human neutrophils. Klin Wochenschr (1973) 0.84
Allosteric transformation of reduced nicotinamide adenine dinucleotide (phosphate) oxidase induced by phagocytosis in human polymorphonuclear leukocytes. Infect Immun (1978) 0.81
Studies on the effect of serum and proteins on in vitro-induced neutrophil activation. J Reticuloendothel Soc (1978) 0.81
Subcellular distribution of nitroblue tetrazolium reductase (NBT-R) in human polymorphonuclear leukocytes (PMN). J Lab Clin Med (1975) 0.80
Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus. Science (1980) 3.68
Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61
A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol (1997) 3.25
Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis (1994) 2.91
Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis (1997) 2.82
Fibronectin binding to Staphylococcus aureus. J Biol Chem (1982) 2.54
Identification, cloning, and initial characterization of rot, a locus encoding a regulator of virulence factor expression in Staphylococcus aureus. J Bacteriol (2000) 2.52
Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun (1989) 2.36
Fibronectin mediates attachment of Staphylococcus aureus to human neutrophils. Blood (1982) 1.93
Phagocytosis of Staphylococcus aureus by cultured bovine aortic endothelial cells: model for postadherence events in endovascular infections. Infect Immun (1986) 1.93
Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts. Infect Immun (1995) 1.85
Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun (1996) 1.79
Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers. Infect Immun (1987) 1.55
Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus alpha-hemolysin. Microb Pathog (1988) 1.46
Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes. Infect Immun (1975) 1.46
Fibronectin-induced agglutination of Staphylococcus aureus correlates with invasiveness. J Lab Clin Med (1984) 1.46
Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J Antimicrob Chemother (1997) 1.44
Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis (1996) 1.43
Protection of mice against lethal endotoxemia by a lipid A precursor. Infect Immun (1986) 1.42
Bloodstream infections caused by small-colony variants of coagulase-negative staphylococci following pacemaker implantation. Clin Infect Dis (1999) 1.39
Coagulase-negative staphylococci. Pathogens have major role in nosocomial infections. Postgrad Med (2001) 1.38
Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol (2001) 1.37
Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis (1993) 1.34
Adhesion of Staphylococcus aureus to surface-bound platelets: role of fibrinogen/fibrin and platelet integrins. J Infect Dis (1993) 1.34
Elicitation of peritoneal polymorphonuclear neutrophils from mice. J Immunol Methods (1982) 1.32
Staphylococcus aureus small colony variants, electron transport and persistent infections. Int J Antimicrob Agents (2000) 1.31
Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect (2014) 1.18
Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem (1998) 1.17
Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res (1991) 1.16
Effects of subinhibitory concentrations of antibiotics on Staphylococcus aureus interactions with fibronectin. J Antimicrob Chemother (1983) 1.16
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem (1996) 1.12
Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin. Infect Immun (1987) 1.09
Blastomycosis is a serious disease, but let's not raise fears without conclusive data. WMJ (2001) 1.07
Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus aureus adhesion to surface-bound fibrinogen under flow. Infect Immun (1995) 1.06
Role of host and bacterial factors in modulating staphylococcal adhesion to implanted polymer surfaces. J Biomater Appl (1990) 1.05
Role of fibronectin in human monocyte and macrophage bactericidal activity. Infect Immun (1985) 1.05
Subinhibitory concentrations of antibiotics alter fibronectin binding to Staphylococcus aureus. Antimicrob Agents Chemother (1983) 1.04
Toward an understanding of biomaterial infections: a complex interplay between the host and bacteria. J Lab Clin Med (2000) 1.04
Immunoelectron microscopic localization of fibronectin in adherence of Staphylococcus aureus to cultured bovine endothelial cells. J Infect Dis (1989) 1.03
Host defences and the vaginal mucosa. A re-evaluation. Scand J Urol Nephrol Suppl (1984) 1.00
Activation and inhibition of Limulus amebocyte lysate coagulation by chemically defined substructures of lipid A. Infect Immun (1985) 1.00
Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation (1997) 0.97
Genetic differences in oxygen toxicity are correlated with cytochrome P-450 inducibility. Proc Natl Acad Sci U S A (1985) 0.96
Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X. Infect Immun (1991) 0.95
Lipid X protects mice against fatal Escherichia coli infection. Infect Immun (1988) 0.95
Bacterial colonization of functionalized polyurethanes. Biomaterials (2000) 0.94
Novel animal model for studying the molecular mechanisms of bacterial adhesion to bone-implanted metallic devices: role of fibronectin in Staphylococcus aureus adhesion. J Orthop Res (1996) 0.92
A low-fibronectin-binding mutant of Staphylococcus aureus 879R4S has Tn918 inserted into its single fnb gene. Microbiology (1996) 0.91
Pulmonary pathophysiological changes in sheep caused by endotoxin precursor, lipid X. J Appl Physiol (1985) (1985) 0.90
Staphylococcus aureus small colony variants: formation and clinical impact. Int J Clin Pract Suppl (2000) 0.89
Haemophilus parainfluenzae vertebral osteomyelitis. Am J Med Sci (1987) 0.87
In vitro study of antiviral activity of immune spleen cells in experimental Venezuelan equine encephalomyelitis infection in mice. J Immunol (1974) 0.86
Comparative study of lipopolysaccharide-, lipid IVa-, and lipid X-induced tumor necrosis factor production in murine macrophage-like cell lines. Adv Exp Med Biol (1990) 0.86
Quantitative comparison of shear-dependent Staphylococcus aureus adhesion to three polyurethane ionomer analogs with distinct surface properties. J Biomed Mater Res (1997) 0.83
Recombinant interferon-gamma preserves human granulocyte bactericidal and chemoluminescence activities. J Infect Dis (1993) 0.83
Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Antimicrob Agents Chemother (2012) 0.83
Small colony variants of Staphylococci: a link to persistent infections. Berl Munch Tierarztl Wochenschr (2000) 0.82
Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves. Am J Vet Res (1993) 0.82
Simple procedure for measuring neutrophil chemiluminescence. J Clin Microbiol (1981) 0.82
Inefficient in vitro killing of virulent or nonvirulent Salmonella typhimurium by murine polymorphonuclear neutrophils. Can J Microbiol (1984) 0.81
Bacterial lipopolysaccharide-stimulated GTPase activity in RAW 264.7 macrophage membranes. Biochem J (1991) 0.81
Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor. Cancer (1992) 0.81
Normalization of intracellular calcium: a sweet solution to neutrophil dysfunction in diabetes? Ann Intern Med (1995) 0.80
Elimination and tissue distribution of the monosaccharide lipid A precursor, lipid X, in mice and sheep. Antimicrob Agents Chemother (1988) 0.80
Bacterial adhesion to functionalized polyurethanes. J Biomater Sci Polym Ed (1999) 0.79
Pulmonary pressor responses in sheep to chemically defined precursors of E. coli endotoxin. J Appl Physiol (1985) (1987) 0.79
Bacterial sepsis in patients with acquired immunodeficiency syndrome. Crit Care Med (2001) 0.78
[Development of gentamicin-resistant Small Colony Variants of S. aureus after implantation of gentamicin chains in osteomyelitis as a possible cause of recurrence]. Z Orthop Ihre Grenzgeb (1998) 0.78
Nuclear translocation of NF-kappaB in lipopolysaccharide-treated macrophages fails to correspond to endotoxicity: evidence suggesting a requirement for a gamma interferon-like signal. Infect Immun (1998) 0.78
Salicylate-induced enzymuria: comparison with other anti-inflammatory agents. Am J Med (1978) 0.78
Alterations in clinical, hematological and metabolic variables in bovine neonatal endotoxemia. Can J Vet Res (1995) 0.78
New drugs for the treatment of septic shock. Crit Care Med (2001) 0.75
Cilastatin does not alter superoxide dismutase activity. Antimicrob Agents Chemother (1985) 0.75
Effect of Staphylococcus aureus enterotoxin F on human neutrophil oxidative metabolism. J Infect Dis (1983) 0.75
Potential risk factors for developing apoptosis during septic shock. Crit Care Med (2000) 0.75
Paradoxical neutrophil activation and coagulopathy during the recovery phase after endotoxemia. Crit Care Med (2001) 0.75
Renal vein thrombosis distal to patent splenorenal shunt. JAMA (1971) 0.75
The pathogenesis of S. aureus endocarditis. J Lab Clin Med (1989) 0.75
University of California/Davis Interdepartmental Conference on gram-negative septicemia. Rev Infect Dis (1991) 0.75
Oxidative metabolism of circulating neutrophils in infantile (Philadelphia chromosome-negative) chronic myelogenous leukemia. Pediatr Hematol Oncol (1986) 0.75
Lipopolysaccharide-induced priming of the murine macrophage-like cell line J774A.1 for enhanced production of reactive oxygen intermediates is blocked by antiserum to murine interferon beta. Adv Exp Med Biol (1990) 0.75
Infectious diseases in Wisconsin. WMJ (1998) 0.75
Effect of chelating agents and superoxide on human neutrophil NAD(P)H oxidation. Anal Biochem (1984) 0.75
Lipopolysaccharide, but not lethal infection, releases tumor necrosis factor in mice. Adv Exp Med Biol (1990) 0.75